Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, October 2003, p. 3233-3239, Vol. 47, No. 10
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.10.3233-3239.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Inhibition of Gene Expression in Escherichia coli by Antisense Phosphorodiamidate Morpholino Oligomers
B. L. Geller,1,2* J. D. Deere,2 D. A. Stein,2 A. D. Kroeker,2 H. M. Moulton,2 and P. L. Iversen2
Oregon State University,1
AVI Biopharma, Inc., Corvallis, Oregon2
Received 26 February 2003/
Returned for modification 24 April 2003/
Accepted 2 July 2003
Antisense phosphorodiamidate morpholino oligomers (PMOs) were tested for the ability to inhibit gene expression in Escherichia coli. PMOs targeted to either a myc-luciferase reporter gene product or 16S rRNA did not inhibit luciferase expression or growth. However, in a strain with defective lipopolysaccharide (lpxA mutant), which has a leaky outer membrane, PMOs targeted to the myc-luciferase or acyl carrier protein (acpP) mRNA significantly inhibited their targets in a dose-dependent response. A significant improvement was made by covalently joining the peptide (KFF)3KC to the end of PMOs. In strains with an intact outer membrane, (KFF)3KC-myc PMO inhibited luciferase expression by 63%. A second (KFF)3KC-PMO conjugate targeted to lacI mRNA induced ß-galactosidase in a dose-dependent response. The end of the PMO to which (KFF)3KC is attached affected the efficiency of target inhibition but in various ways depending on the PMO. Another peptide-lacI PMO conjugate was synthesized with the cationic peptide CRRRQRRKKR and was found not to induce ß-galactosidase. We conclude that the outer membrane of E. coli inhibits entry of PMOs and that (KFF)3KC-PMO conjugates are transported across both membranes and specifically inhibit expression of their genetic targets.
* Corresponding author. Mailing address: Department of Microbiology, Nash Hall 220, Oregon State University, Corvallis, OR 97331-3804. Phone: (541) 737-1845. Fax: (541) 737-0496. E-mail:
gellerb{at}orst.edu.
Antimicrobial Agents and Chemotherapy, October 2003, p. 3233-3239, Vol. 47, No. 10
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.10.3233-3239.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Mellbye, B. L., Weller, D. D., Hassinger, J. N., Reeves, M. D., Lovejoy, C. E., Iversen, P. L., Geller, B. L.
(2009). Cationic phosphorodiamidate morpholino oligomers efficiently prevent growth of Escherichia coli in vitro and in vivo. J Antimicrob Chemother
0: dkp392v1-dkp392
[Abstract]
[Full Text]
-
Mitev, G. M., Mellbye, B. L., Iversen, P. L., Geller, B. L.
(2009). Inhibition of Intracellular Growth of Salmonella enterica Serovar Typhimurium in Tissue Culture by Antisense Peptide-Phosphorodiamidate Morpholino Oligomer. Antimicrob. Agents Chemother.
53: 3700-3704
[Abstract]
[Full Text]
-
Woodford, N., Wareham, D. W., on behalf of the UK Antibacterial Antisense Study,
(2009). Tackling antibiotic resistance: a dose of common antisense?. J Antimicrob Chemother
63: 225-229
[Abstract]
[Full Text]
-
Mellbye, B. L., Puckett, S. E., Tilley, L. D., Iversen, P. L., Geller, B. L.
(2009). Variations in Amino Acid Composition of Antisense Peptide-Phosphorodiamidate Morpholino Oligomer Affect Potency against Escherichia coli In Vitro and In Vivo. Antimicrob. Agents Chemother.
53: 525-530
[Abstract]
[Full Text]
-
Tilley, L. D., Mellbye, B. L., Puckett, S. E., Iversen, Patrick. L., Geller, B. L.
(2007). Antisense peptide-phosphorodiamidate morpholino oligomer conjugate: dose-response in mice infected with Escherichia coli. J Antimicrob Chemother
59: 66-73
[Abstract]
[Full Text]
-
Gruegelsiepe, H., Brandt, O., Hartmann, R. K.
(2006). Antisense Inhibition of RNase P: MECHANISTIC ASPECTS AND APPLICATION TO LIVE BACTERIA. J. Biol. Chem.
281: 30613-30620
[Abstract]
[Full Text]
-
Tilley, L. D., Hine, O. S., Kellogg, J. A., Hassinger, J. N., Weller, D. D., Iversen, P. L., Geller, B. L.
(2006). Gene-Specific Effects of Antisense Phosphorodiamidate Morpholino Oligomer-Peptide Conjugates on Escherichia coli and Salmonella enterica Serovar Typhimurium in Pure Culture and in Tissue Culture.. Antimicrob. Agents Chemother.
50: 2789-2796
[Abstract]
[Full Text]
-
Tan, X.-X., Actor, J. K., Chen, Y.
(2005). Peptide Nucleic Acid Antisense Oligomer as a Therapeutic Strategy against Bacterial Infection: Proof of Principle Using Mouse Intraperitoneal Infection. Antimicrob. Agents Chemother.
49: 3203-3207
[Abstract]
[Full Text]
-
Dryselius, R., Nekhotiaeva, N., Good, L.
(2005). Antimicrobial synergy between mRNA- and protein-level inhibitors. J Antimicrob Chemother
56: 97-103
[Abstract]
[Full Text]
-
Geller, B. L., Deere, J., Tilley, L., Iversen, P. L.
(2005). Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis. J Antimicrob Chemother
55: 983-988
[Abstract]
[Full Text]
-
Deere, J., Iversen, P., Geller, B. L.
(2005). Antisense Phosphorodiamidate Morpholino Oligomer Length and Target Position Effects on Gene-Specific Inhibition in Escherichia coli. Antimicrob. Agents Chemother.
49: 249-255
[Abstract]
[Full Text]